Molecular Mechanisms of Vascular Relaxation

血管舒张的分子机制

基本信息

  • 批准号:
    7470535
  • 负责人:
  • 金额:
    $ 217.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-08-02 至 2010-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Many cardiovascular diseases are characterized by disordered vascular function. Abnormalities in vascular smooth muscle cell (VSMC) tone are important in the pathogenesis of hypertension and atherosclerosis, but are not well understood. The long-term objective of this PPG is to understand the complex underlying molecular mechanisms that regulate vascular tone in health and disease. The fundamental hypothesis that will be tested is that loss of the normal function of the critical proteins that regulate vascular smooth muscle cell contraction and relaxation directly causes abnormal vasomotion and disorders of blood pressure regulation. The program we propose takes advantage of an extensive and well-developed infrastructure and ongoing collaborations between the Tufts-New England Medical Center Molecular Cardiology research Institute (MCRI), its NHLBI SCOR in Ischemic Heart Disease, the Framingham Heart Study, and the Housman Genomics Laboratory at MIT. Four projects are proposed: P1: "Genetics of Vasorelaxation and Cardiovascular Responses"; P2: "Mechanisms of PKG-mediated Vascular Relaxation"; P3: "BKca Channel Regulation by PKG in Vascular Smooth Muscle"; and P4: "Vascular Dysfunction as an Etiology of Hypertension" in Mouse Models. Three Cores are also proposed (Genomics; Mouse; Administrative). The VSMC proteins that are the specific focus of this proposal include three proteins that we show are essential for normal blood pressure: RGS2, the regulator of Gq-protein signaling; estrogen receptor a; and the BKca potassium channel (a and a subunits), as well as the two physiologically most relevant myosin phosphatase regulatory kinases, Rho Kinase (ROCK) and PKGIa, the effector of nitric oxide/cGMO. Genetically altered mice for PKGI, RGS2, ERa and the BKca channel all demonstrate vascular contractile abnormalities and hypertension. This PPG provides extensive preliminary data from human genomic studies, intact mice, mouse vascular rings, cultured human and mouse vascular cells, patch-clamping, signal transduction experiments, and detailed renal physiology. The ability of the assembled investigators to collaborate effectively is demonstrated throughout the proposal. An important corollary of the hypothesis to be tested is the concept that hypertension can arise from primary abnormalities of the VSMC proteins that regulate vascular relaxation. To formally test this hypothesis, targeted mutations in these critical VSMC regulatory genes are introduced into mice and sought in humans. The highly integrated studies of this PPG are likely to lead to new diagnostic and therapeutic approaches to hypertension and related cardiovascular diseases.
描述(由申请人提供): 许多心血管疾病的特征是血管功能紊乱。 血管平滑肌细胞(VSMC)张力异常在高血压和动脉粥样硬化的发病机制中具有重要意义,但目前尚不清楚。 PPG的长期目标是了解在健康和疾病中调节血管张力的复杂潜在分子机制。 将要检验的基本假设是,调节血管平滑肌细胞收缩和舒张的关键蛋白质的正常功能的丧失直接导致异常血管运动和血压调节障碍。 我们提出的计划利用了塔夫茨-新英格兰医学中心分子心脏病研究所(MCRI),其缺血性心脏病NHLBI SCOR,心脏病研究和麻省理工学院Housman基因组学实验室之间广泛而发达的基础设施和持续的合作。 提出了四个项目:P1:P2:“PKG介导的血管舒张机制”; P3:“血管平滑肌中PKG对BKca通道的调节”; P4:“血管功能障碍作为高血压的病因”。 还提出了三个核心(基因组学;小鼠;管理)。 VSMC蛋白是该提案的具体焦点,包括我们显示对正常血压至关重要的三种蛋白质:RGS 2,Gq蛋白信号传导的调节剂;雌激素受体a;和BKca钾通道(a和a亚基),以及两种生理上最相关的肌球蛋白磷酸酶调节激酶,Rho激酶(ROCK)和PKGIa,一氧化氮/cGMO的效应子。 PKGI、RGS 2、ER α和BKca通道的基因改变的小鼠都表现出血管收缩异常和高血压。 该PPG提供了来自人类基因组研究、完整小鼠、小鼠血管环、培养的人类和小鼠血管细胞、膜片钳、信号转导实验和详细的肾脏生理学的广泛初步数据。 在整个提案中,都证明了集合起来的调查人员进行有效合作的能力。 有待检验的假设的一个重要推论是,高血压可由调节血管舒张的VSMC蛋白的原发性异常引起。 为了正式验证这一假设,将这些关键VSMC调控基因中的靶向突变引入小鼠并在人类中寻找。 PPG的高度整合研究可能会导致高血压和相关心血管疾病的新的诊断和治疗方法。

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Measuring the influence of the BKCa {beta}1 subunit on Ca2+ binding to the BKCa channel.
  • DOI:
    10.1085/jgp.200810129
  • 发表时间:
    2009-02
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Sweet, Tara-Beth;Cox, Daniel H.
  • 通讯作者:
    Cox, Daniel H.
Application of gene network analysis techniques identifies AXIN1/PDIA2 and endoglin haplotypes associated with bicuspid aortic valve.
  • DOI:
    10.1371/journal.pone.0008830
  • 发表时间:
    2010-01-21
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Wooten EC;Iyer LK;Montefusco MC;Hedgepeth AK;Payne DD;Kapur NK;Housman DE;Mendelsohn ME;Huggins GS
  • 通讯作者:
    Huggins GS
Formin homology 2 domain containing 3 variants associated with hypertrophic cardiomyopathy.
  • DOI:
    10.1161/circgenetics.112.965277
  • 发表时间:
    2013-02
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Wooten EC;Hebl VB;Wolf MJ;Greytak SR;Orr NM;Draper I;Calvino JE;Kapur NK;Maron MS;Kullo IJ;Ommen SR;Bos JM;Ackerman MJ;Huggins GS
  • 通讯作者:
    Huggins GS
Measurements of the BKCa channel's high-affinity Ca2+ binding constants: effects of membrane voltage.
  • DOI:
    10.1085/jgp.200810094
  • 发表时间:
    2008-11
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Sweet, Tara-Beth;Cox, Daniel H.
  • 通讯作者:
    Cox, Daniel H.
Mind the dbGAP: the application of data mining to identify biological mechanisms.
注意 dbGAP:应用数据挖掘来识别生物机制。
  • DOI:
    10.1124/mi.11.2.6
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Wooten,EricC;Huggins,GordonS
  • 通讯作者:
    Huggins,GordonS
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL E MENDELSOHN其他文献

MICHAEL E MENDELSOHN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL E MENDELSOHN', 18)}}的其他基金

Nitric Oxide Signaling Mechanisms in Vascular Cells
血管细胞中的一氧化氮信号传导机制
  • 批准号:
    7822184
  • 财政年份:
    2009
  • 资助金额:
    $ 217.91万
  • 项目类别:
Vascular Surgery - Estrogen and the Injury Response
血管外科 - 雌激素和损伤反应
  • 批准号:
    7822191
  • 财政年份:
    2009
  • 资助金额:
    $ 217.91万
  • 项目类别:
Cellular Fluorescence-Contractility Imaging System
细胞荧光收缩成像系统
  • 批准号:
    6877423
  • 财政年份:
    2005
  • 资助金额:
    $ 217.91万
  • 项目类别:
Molecular Biology of the Vasculature
脉管系统的分子生物学
  • 批准号:
    7058649
  • 财政年份:
    2005
  • 资助金额:
    $ 217.91万
  • 项目类别:
CELLULAR FLUORESCENCE-CONTRACTILITY IMAGING SYSTEM: CARDIOVASCULAR RESEARCH
细胞荧光收缩成像系统:心血管研究
  • 批准号:
    7166559
  • 财政年份:
    2005
  • 资助金额:
    $ 217.91万
  • 项目类别:
Molecular Mechanisms of Vascular Relaxation
血管舒张的分子机制
  • 批准号:
    7267623
  • 财政年份:
    2004
  • 资助金额:
    $ 217.91万
  • 项目类别:
ESTROGEN RECEPTOR REGULATION OF NO SYNTHASES
无合酶的雌激素受体调节
  • 批准号:
    6858700
  • 财政年份:
    2004
  • 资助金额:
    $ 217.91万
  • 项目类别:
Core A-- Administration Core
核心A——管理核心
  • 批准号:
    7001179
  • 财政年份:
    2004
  • 资助金额:
    $ 217.91万
  • 项目类别:
Molecular Mechanisms of Vascular Relaxation
血管舒张的分子机制
  • 批准号:
    6812078
  • 财政年份:
    2004
  • 资助金额:
    $ 217.91万
  • 项目类别:
Molecular Mechanisms of Vascular Relaxation
血管舒张的分子机制
  • 批准号:
    7113669
  • 财政年份:
    2004
  • 资助金额:
    $ 217.91万
  • 项目类别:

相似国自然基金

Exploring the Intrinsic Mechanisms of CEO Turnover and Market
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    万元
  • 项目类别:
    外国学者研究基金
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
  • 批准号:
    W2433169
  • 批准年份:
    2024
  • 资助金额:
    万元
  • 项目类别:
    外国学者研究基金项目

相似海外基金

Molecular mechanisms of ALK1 signalling suppression of VEGF signalling during vascular development
血管发育过程中 ALK1 信号抑制 VEGF 信号的分子机制
  • 批准号:
    22K15361
  • 财政年份:
    2022
  • 资助金额:
    $ 217.91万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Novel molecular mechanisms of vascular smooth muscle cell-mediated large and small artery calcification
血管平滑肌细胞介导大小动脉钙化的新分子机制
  • 批准号:
    10670415
  • 财政年份:
    2022
  • 资助金额:
    $ 217.91万
  • 项目类别:
Novel molecular mechanisms of vascular smooth muscle cell-mediated large and small artery calcification
血管平滑肌细胞介导大小动脉钙化的新分子机制
  • 批准号:
    10507440
  • 财政年份:
    2022
  • 资助金额:
    $ 217.91万
  • 项目类别:
Molecular mechanisms of vascular calcification and their connection to coronary disease risk
血管钙化的分子机制及其与冠心病风险的关系
  • 批准号:
    10673742
  • 财政年份:
    2022
  • 资助金额:
    $ 217.91万
  • 项目类别:
Investigation of the molecular mechanisms of vascular endothelial dysfunction in Hutchinson-Gilford Progeria Syndrome through in vitro 2D and 3D models
通过体外2D和3D模型研究Hutchinson-Gilford早衰综合症血管内皮功能障碍的分子机制
  • 批准号:
    10321677
  • 财政年份:
    2021
  • 资助金额:
    $ 217.91万
  • 项目类别:
Analysis of the molecular mechanisms underlying the aging process in vascular endothelial cells.
血管内皮细胞衰老过程的分子机制分析。
  • 批准号:
    21K20741
  • 财政年份:
    2021
  • 资助金额:
    $ 217.91万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Use of a novel transgenic mouse model to probe the molecular mechanisms of lipoprotein(a) pathogenicity in atherosclerotic vascular disease
使用新型转基因小鼠模型探讨脂蛋白(a)在动脉粥样硬化性血管疾病中致病性的分子机制
  • 批准号:
    458698
  • 财政年份:
    2021
  • 资助金额:
    $ 217.91万
  • 项目类别:
    Studentship Programs
Insights into the molecular mechanisms regulating vascular and immune metabolism in vascular diseases
深入探讨血管疾病中血管和免疫代谢调节的分子机制
  • 批准号:
    10543173
  • 财政年份:
    2021
  • 资助金额:
    $ 217.91万
  • 项目类别:
Insights into the molecular mechanisms regulating vascular and immune metabolism in vascular diseases
深入探讨血管疾病中血管和免疫代谢调节的分子机制
  • 批准号:
    10329985
  • 财政年份:
    2021
  • 资助金额:
    $ 217.91万
  • 项目类别:
Elucidating the Molecular Mechanisms Underlying LYST-mediated Tissue Engineered Vascular Graft Stenosis
阐明 LYST 介导的组织工程血管移植狭窄的分子机制
  • 批准号:
    10378148
  • 财政年份:
    2021
  • 资助金额:
    $ 217.91万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了